Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
2
×
aimmune therapeutics
alopecia areata
amarin
arena pharmaceuticals
avapritinib
blueprint medicines
boehringer ingelheim
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cadent therapeutics
cancer
cancer immunotherapy
celgene
centers for disease control and prevention
centrexion therapeutics
clinical study
clinical trials
colucid pharmaceuticals
concert pharmaceuticals
data
detroit blog main
detroit top stories
disease
dragonfly therapeutics
eli lilly
enzyme
esophageal cancer
fda
gag
galcanezumab
gene editing
gene therapy
What
little
2
×
arena’s
benefit
bio
bounty
cig
comeback
companies
corner
deals
delivered
editing
expressing
gene
going
humans
ipo
isn't
landmark
life
medicine
moderna’s
morning
nasdaq
number
phase
reported
reports
results
roundup
sangamo
science
study
survey
thanks
thanksgiving
therapeutics
trial
u.s
week
Language
Current search:
little
×
" san francisco top stories "
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More